PreviousEntry : {18CBAB44-205F-4C19-85D7-1B1D30A8F9EC} | Display Title : West Reports on Corporate Responsibility for 2016
NextEntry : {D531701C-FB9C-44F8-934E-AB5567F7DA5B} | Display Title : West Reports on Corporate Responsibility for 2016
Sources

1Intradermal delivery of vaccines: potential benefits and current challenges, January 2011 http://www.who.int/bulletin/volumes/89/3/10-079426

Intradermal vaccination using the novel microneedle device MicronJet600: Past, present, and future. Human Vaccines & Immunotherapeutics 11:4, 991–997; April 2015; http://www.tandfonline.com/doi/full/10.1080/21645515.2015.1010871

2A phase 1, open-label, randomized study to compare the immunogenicity and safety of different administration routes and doses of virosomal influenza vaccine in elderly. http://www.sciencedirect.com/science/article/pii/S0264410X16308040

Early priming with inactivated poliovirus vaccine (IPV) and intradermal fractional dose IPV administered by a microneedle device: A randomized controlled trial. Vaccine 33 (2015) 6816–6822. http://www.sciencedirect.com/science/article/pii/S0264410X15013158

Previous Next
Doug Hostetler

Doug Hostetler

Principle SME, Admin. Systems, TCS

Subscribe to receive the latest blog post
X
Cookies help us improve your website experience.
By using our website, you agree to our use of cookies.
Confirm Reject
X
Cookies help us improve your website experience.
By using our website, you agree to our use of cookies.
Confirm Reject
X
Cookies help us improve your website experience.
By using our website, you agree to our use of cookies.
Confirm Reject
X
Cookies help us improve your website experience.
By using our website, you agree to our use of cookies.
Confirm Reject